Sirlander schreef op 6 juli 2020 14:32:
COVID-19 Impact on launch plans
• Drug shortages and procedural backlogs creating pent up demand
• Heightened value proposition (increasing patient throughput) for both drugs
• Planning to launch both drugs in the coming months as access to decision-makers improves
ik hoor de kassa al rinkelen ;)